Details for Patent: 5,206,366

Title:	Process for preparing aryl piperazinyl-heterocyclic compounds
Abstract:	A process for preparing a compounds of the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof, which comprises reacting a monosubstituted piperazine of the formula ##STR2## with an alkyl halide containing compound of the formula ##STR3## in water with a reagent to neutralize the hydrohalic acid and refluxing the mixture under conditions which are suitable to effect the coupling of said monosubstituted piperazines with said alkyl halide containing compound.
Inventor(s):	Bowles; Paul (Groton, CT)
Assignee:	Pfizer Inc. (New York, NY)
Filing Date:	Aug 26, 1992
Application Number:	07/936,179
Claims:	1. A process for preparing a compound of the formula: ##STR8## or a pharmaceutically acceptable acid addition salt thereof, wherein Ar is naphthyl optionally substituted by fluoro, chloro, trifluoromethyl, methoxy, cyano or nitro; quinolyl; 6-hydroxy-8-quinolyl; isoquinolyl; quinazolyl; benzoisothiazolyl or an oxide or dioxide thereof, each optionally substituted by fluoro, chloro, trifluoromethyl, methoxy, cyano, or nitro; benzothiazolyl; benzothiadiazolyl; benzotriazolyl; benzoxazolyl; benzoxazolonyl; indolyl; indanyl optionally substituted by one or two fluoro; 3-indazolyl optionally substituted by 1-trifluoromethylphenyl; or phthalazinyl; n is 1 or 2; and X and Y together with the phenyl to which they are attached form quinolyl; 2-hydroxyquinolyl; benzothiazolyl; 2-aminobenzothiazolyl; benzoisothiazolyl; indazolyl; 2-hydroxyindazolyl; indolyl; spiro[cyclopentane-1,3'-indolinyl-indolinyl]; oxindolyl optionally substituted by one to three of (C.sub.1 -C.sub.3)alkyl, or one of chloro, fluoro or phenyl, said phenyl optionally substituted by one chloro or fluoro; benzoxazolyl; 2-aminobenzoxazolyl; benzoxazolonyl; 2-aminobenzoxazolinyl; benzothiazolonyl; benzoimidazolonyl; or benzotriazolyl; which comprises reacting a monosubstituted piperazine of the formula ##STR9## wherein AR is as defined above, with an alkyl halide containing compound of the formula ##STR10## wherein n, X and Y are as defined above and Hal is fluoro, chloro, bromo or iodo, in water with a reagent to neutralize the hydrohalic acid and refluxing the mixture under conditions which are suitable to effect the coupling of said monosubstituted piperazines with said alkyl halide containing compound and, if desired, preparing the corresponding pharmaceutically acceptable acid addition salt. 2. A process according to claim 1 wherein the coupling of the monosubstituted piperazine with the alkyl halide containing compound is effected in the presence of a neutralizing agent. 3. A process according to claim 2 wherein from about one to five molar equivalents of a neutralizing agent based on the substrate not present in excess is used with from about three to ten volumes of water based on the weight of the substrate not present in excess. 4. A process according to claim 3 wherein about two molar equivalents of a neutralizing agent and about five volumes of water are used. 5. A process according to claim 4 wherein the neutralizing agent is selected from the group consisting of alkali metal carbonates, alkaline earth metal carbonates, bicarbonates, hydrides and tertiary amines. 6. A process according to claim 5 wherein the neutralizing agent is sodium carbonate. 7. A process according to claim 6 wherein the piperazine, alkyl halide containing compound, sodium carbonate and water are combined and heated to reflux. 8. A process according to claim 7 wherein the temperature of reflux is about 100.degree. C. 9. A process according to claim 1 wherein the compound of the formula I is 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydr o-2-H-indol-2-one hydrochloride. 10. A process according to claim 1 which comprises reacting the monosubstituted piperazine with the alkyl halide containing compound in water and a neutralizing agent; refluxing the mixture for at least about 8 to 12 hours; cooling the mixture and filtering off the product. 11. A process according to claim 10 wherein from about one to five molar equivalents of a neutralizing agent based on the substrate not present in excess is used with from abut three to ten volumes of water based on the weight of the substrate not present in excess. 12. A process according to claim 11 wherein about two molar equivalents of a neutralizing agent and about five volumes of water are used. 13. A process according to claim 12 wherein the neutralizing agent is sodium carbonate. 14. A process according to claim 13 wherein the piperazine, alkyl halide containing compound, sodium carbonate and water are combined and heated to reflux. 15. A process according to claim 14 wherein the temperature of reflux is about 100.degree. C. 16. A process according to claim 10 wherein the compound of formula I is 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydr o-2H-indol-2-one hydrochloride.